How many insider declarations has Chow Gregory K. filed?

Chow Gregory K. has filed 2 public insider declarations with SEC (Form 4).

What is Chow Gregory K.'s role?

Chow Gregory K.'s reported role is not specified by the regulator across the filings.

Which companies does Chow Gregory K. report trades for?

Chow Gregory K. reports trades for Sutro Biopharma, INC..

What is Chow Gregory K.'s declared buy vs sell volume?

Across the available history, declared buys total 14k€ and disposals 0.

← Executives ★ Sign in to follow

CG

Chow Gregory K.

CFO

·SEC (Form 4)

Sutro Biopharma, INC.

0

申报总数

0

公司

€13,736

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+29.4%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by Chow Gregory K.. Officer active across 1 company, notably Sutro Biopharma, INC.. In total, 2 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €14k. History available since 15 October 2025. The latest transaction was disclosed on 2 June 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Chow Gregory K.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Sutro Biopharma, INC. (US)

申报2 总计

◇

Chow Gregory K.

CFO高管2026年6月2日Sutro Biopharma, INC.

0SEC ↗

2,500 股0Common StockSEC:0001761333-26-000005:0

▲

Chow Gregory K.

CFO高管2025年10月15日Sutro Biopharma, INC.

US$15,99849SEC ↗

19,750 股@ US$0.81100.0% 占其流量Common StockSEC:0001761333-25-000005:0

标准退出：2026年1月13日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

CG

Chow Gregory K.

CFO

·SEC (Form 4)

Sutro Biopharma, INC.

0

申报总数

0

公司

€13,736

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+29.4%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by Chow Gregory K.. Officer active across 1 company, notably Sutro Biopharma, INC.. In total, 2 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €14k. History available since 15 October 2025. The latest transaction was disclosed on 2 June 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.